Acute cellular rejection following human heart transplantation is associated with increased expression of vitronectin receptor (integrin αvβ3)

American Journal of Transplantation

Volumn 2, Issue 2, 2002, Pages 129-133

  Yamani, Mohamad H ^a   Yang, Jiacheng ^a   Masri, Carolyna S ^a   Ratliff, Norman B ^a   Bond, Meredith ^a   Starling, Randall C ^a   McCarthy, Patrick ^a   Plow, Edward ^a   Young, James B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cytokines; Heart transplantation; Integrins; Tissue factor

Indexed keywords

CYTOKINE; PEROXIDASE; THROMBOPLASTIN; VITRONECTIN RECEPTOR;

ADULT; AGED; ALLOGRAFT; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL AGGREGATION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENDOTHELIUM CELL; GRAFT REJECTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INFLAMMATION; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; UPREGULATION; WESTERN BLOTTING;

ACUTE DISEASE; DOWN-REGULATION; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; POSTOPERATIVE PERIOD; RECEPTORS, VITRONECTIN; T-LYMPHOCYTES; TIME FACTORS;

EID: 0036487976     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.020203.x     Document Type: Article

References (30)

1. Hynes RO. Integrins: a family of cell surface receptors. Cell 1987; 48: 549-554.
2. Horton MA. The alpha v beta 3 integrin 'vitronectin receptor'. Int J Biochem Cell Biol 1997; 29: 721-725.
3. Soldi R, Mitola S, Strasly M. Role of alpha v beta 3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 1999; 18: 882-892.
4. Byzova T, Rabbani R, D'Souza SE et al. Role of integrin αvβ3 in vascular biology. Thromb Haemost 1998; 80: 726-734.
5. Byzova T, Plow E. Activation of αvβ3 on vascular cells controls recognition of prothrombin. J Cell Biol 1998; 143: 2081-2092.
6. Suehiro K, Plow E. Ligand recognition by β3 integrins. Keio J Med 1997; 46: 111-114.
7. Hermann P, Armant M, Brown E et al. The vitronectin receptor and its associated CD47 molecule mediates proinflammatory cytokine synthesis in human monocytes by interaction with soluble CD23. J Cell Biol 1999; 144: 767-775.
8. Felding-Habermann B, Cheresh DA. Vitronectin and its receptor. Curr Opin Cell Biol 1993; 5: 864-868.
9. Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994; 264: 569-571.
10. Kaul DK, Tsai HM, Liu XD et al. Monoclonal antibodies to αvβ3 (7E3 and LM 609) inhibit sickle red blood cell-endothelium interactions induced by platelet activating factor. Blood 2000; 95: 368-374.
11. Clark EA, Brugge JS. Integrins and signal transduction pathways: The road taken. Science 1995; 268: 233-239.
12. Stromblad S, Cheresh DA. Integrins, angiogenesis and vascular cell survival. Chem Biol 1996; 3: 881-885.
13. Sturmhofel K, Brando C, Martinon F et al. Antigen-independent, integrin mediated T cell activation. J Immunol 1995; 154: 2104-2111.
14. Moulder K, Roberts K, Shevach E et al. The mouse vitronectin receptor is a T cell activation antigen. J Exp Med 1991; 173: 343-348.
15. Roberts K, Yokoyama W, Kehn P et al. The vitronectin receptor serves as an accessory molecule for the activation of a subset of γ/δ T cells. J Exp Med 1991; 173: 231-236.
16. Schecter AD, Rollins BJ, Zhang YJ et al. Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells. J Biol Chem 1997; 272: 28568-28573.
17. Saukkonen JJ, Tantri A, Berman J. Costimulation of CD28-T cells through CD3 and beta 1-integrins induces a limited Th1 cytokine response. Scand J Immunol 1999; 50: 145-149.
18. Yang J, Moravec CS, Sussman MA et al. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation 2000; 102: 3046-3052.
19. Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998; 338: 1813-1821.
20. Colvin RB. Cellular and molecular mechanisms of allograft rejection. Ann Rev Med 1990; 41: 361-375.
21. Coito AJ, Kupiec-Weglinski JW. The emerging role of the extracellular matrix. Graft 2000; 3: S32-S36.
22. Coito AJ, Korom S, Graser E et al. Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients: I. Treatment with connecting segment -1 peptides prevents acute rejection by suppressing intragraft mononuclear cell accumulation, endothelial activation and cytokine expression. Transplantation 1998; 65: 699-706.
23. Yamada A, Nikaido T, Nojima Y et al. Activation of human CD4 T lymphocytes. Interaction of fibronectin with VLA-5 receptor on CD4 cells induces the AP-1 transcription factor. J Immunol 1991; 16: 53-59.
24. Damle NK, Aruffo A. Vascular cell adhesion molecule 1 induces T cell antigen receptor-dependent activation of CD4 T lymphocytes. Proc Natl Acad Sci 1991; 88: 6403-6409.
25. Mawtari K, Liu B, Kent KC. Activation of integrin receptors is required for growth factor-induced smooth muscle cell dysfunction. J Vasc Surg 2000; 31: 375-381.
26. Kitazawa S, Ross F, McHugh K et al. Interleukin-4 induces expression of the integrin αvβ3 via transactivation of the β3 gene. J Biol Chem 1995; 270: 4115-4120.
27. Tremoli E, Camera M, Toschi V et al. Tissue factor in atherosclerosis. Atherosclerosis 1999; 144: 273-283.
28. Mallat Z, Hugel B, Ohan J et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenecity. Circulation 1999; 99: 348-353.
29. Nagayasu T, Saadi S, Holzknecht RA et al. Expression of tissue factor mRNA in cardiac xenografts: Clues to the pathogenesis of acute vascular rejection. Transplantation 2000; 69: 475-482.
30. Yee KO, Rooney MM, Giachelli CM et al. Role of beta 1 and beta 3 integrins in human smooth muscle cell adhesion to and contraction of fibrin clots in vitro. Circ Res 1998; 83: 241-251.